跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NRA-PANTOPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NRA-PANTOPRAZOLE
Authorized
STANDARD
NRA-PANTOPRAZOLE
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
587232463e50662a
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
587232463e50662a
Drug Approval Canada Name
NRA-PANTOPRAZOLE
Product Name
NRA-PANTOPRAZOLE
Status
Marketed
Status Date
2024-05-27
Original Market Date
2018-10-06
Din
02471825
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC02 PANTOPRAZOLE
Atc Name
a 02 bc 02
Aig Number
0133229001
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
PANTOPRAZOLE (PANTOPRAZOLE SODIUM)
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
587232463e50662a
Type
Standard
Back to Health Canada Approvals